Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: pathologic, clinical, and imaging updates.

Stuart D Cook1

  • 1Department of Neurology and Neurosciences, New Jersey Medical School, University of Medicine and Dentistry of New Jersey, Newark, NJ, USA.

Reviews in Neurological Diseases
|April 6, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter to the editor.

Multiple sclerosis and related disorders·2022
Same author

Increased frequency of canine distemper virus-specific antibodies in multiple sclerosis.

Brain and behavior·2020
Same author

Gray Matter Nucleus Hyperintensity After Monthly Triple-Dose Gadopentetate Dimeglumine With Long-term Magnetic Resonance Imaging.

Investigative radiology·2020
Same author

Letter to the editor.

Multiple sclerosis and related disorders·2019
Same author

Stability of visual outcome between 2 and 5 years following corneal transplantation in the UK.

The British journal of ophthalmology·2017
Same author

Long-Term Outcomes of High-Risk Keratoplasty in Patients Receiving Systemic Immunosuppression.

Cornea·2015
Same journal

Narcolepsy: clinical approach to etiology, diagnosis, and treatment.

Reviews in neurological diseases·2012
Same journal

Orofacial pain following an invasive dental procedure.

Reviews in neurological diseases·2012
Same journal

An update on the diagnosis and management of dementing conditions.

Reviews in neurological diseases·2012
Same journal

The neurology of decreased activity: abulia.

Reviews in neurological diseases·2012
Same journal

Progressive personality and language changes in a 62-year-old woman.

Reviews in neurological diseases·2012
Same journal

A rare cause of headache.

Reviews in neurological diseases·2012
See all related articles

The 21st European Committee for Treatment and Research in Multiple Sclerosis Congress in 2005 showcased advancements in multiple sclerosis (MS) research. Key findings from the Thessaloniki meeting offered new insights into MS treatment and patient care strategies.

Area of Science:

  • Neurology
  • Immunology
  • Clinical Research

Background:

  • The European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) is a leading organization in multiple sclerosis (MS) research.
  • The 21st ECTRIMS Congress convened to present cutting-edge findings and foster discussion on MS.
  • Multiple sclerosis is a chronic, inflammatory, demyelinating disease of the central nervous system.

Purpose of the Study:

  • To disseminate key research findings and therapeutic developments presented at the 21st ECTRIMS Congress.
  • To highlight advancements in understanding the pathophysiology of multiple sclerosis.
  • To provide an overview of emerging treatment strategies and clinical trial outcomes in MS.

Main Methods:

  • The abstract summarizes presentations and discussions from the 21st ECTRIMS Congress.

Related Experiment Videos

  • Content includes data from preclinical studies, clinical trials, and epidemiological research.
  • Expert opinions and consensus statements on MS management were also featured.

    • Main Results:

    • Emerging therapies showed promise in modifying disease progression and managing symptoms.
    • New insights into neuroprotection and neuroregeneration were presented.
    • Advances in diagnostic tools and biomarkers for MS were discussed.

    Conclusions:

    • The 21st ECTRIMS Congress underscored significant progress in multiple sclerosis research and treatment.
    • Continued research is vital for developing more effective therapies and improving patient outcomes.
    • Collaboration among researchers and clinicians remains crucial for advancing MS care.